Toggle Navigation
Company
Overview
Management Team
Board of Directors
Investors
Advisory Board
Message from BIO
Pipeline
Overview
GB-102 and GB-103
GB-201, GB-202 and GB-203 – Glaucoma Products
Science
Overview
Ocular Drug Delivery Technology
Primary Open-angle Glaucoma and Ocular Hypertension
Retinal Disease
Glaucoma
Partnerships
logo
Media
Press Releases
Events
Publications and Posters
Careers
Contact
Investors
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.
Ok